$GEHC, the healthcare division of General Electric, reported beating its quarterly profit estimates and raising the low end of its adjusted EPS guidance range for the fiscal year 2023. The company saw strong growth in pharmaceutical diagnostics and margin improvement in imaging, but also experienced margin pressure in ultrasound. GE Healthcare remains confident in its 2023 outlook and continues to innovate for customers and patients. Global Payments ($GPN) also reported its third-quarter 2023 results, with a 5.8% pre-market increase. Lumen Technologies topped third-quarter revenue estimates on strong demand. TG Therapeutics ($TGTX) provided a business update and reported its third-quarter 2023 financial results, resulting in a 20.1% pre-market increase. Generac ($GNRC) reported its third-quarter 2023 results, leading to an 8.3% pre-market increase.
$TGTX (+20.1% pre) TG Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results - GN https://t.co/pWlhPog8eZ
$TGTX (+20.1% pre) TG Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results - GN https://t.co/8MbcgPBJqc
$GNRC (+8.3% pre) Generac Reports Third Quarter 2023 Results https://t.co/Uq1Oa25pJj
Lumen Technologies tops third-quarter revenue estimates on strong demand https://t.co/Z8IIBq2mEi https://t.co/f7ACVFXiBi
GE HealthCare beats quarterly profit estimates on imaging device demand https://t.co/hFqgbS76En https://t.co/egp49BZoeH
$GEHC Q3 beats and raises bottom end of FY outlook. Saw strong growth in pharmaceutical diagnostics, margin improvement in imaging... margin pressure in ultrasound. https://t.co/VkcPfnc2zl
$GPN (+5.8% pre) Global Payments Reports Third Quarter 2023 Results https://t.co/q6n6ZdfBuI
$GEHC (+1.4% pre) GE HealthCare Reports Third Quarter 2023 Financial Results https://t.co/ZryPnaGBT0
$GEHC GE Healthcare beats, raises low end of FY adjusted EPS guidance range. CEO: "We remain confident in our 2023 outlook as we continue to innovate for customers and patients.” https://t.co/cJ9vYUO7Vv